Fenofibrate and Abortion spontaneous - a phase IV clinical study of FDA data

Summary:

Abortion spontaneous is reported as a side effect among people who take Fenofibrate (fenofibrate), especially for people who are 30-39 old, have been taking the drug for 1 - 6 months also take Metformin, and have Hyperlipidaemia.

The phase IV clinical study analyzes which people have Abortion spontaneous when taking Fenofibrate. It is created by eHealthMe based on reports of 39,402 people who have side effects when taking Fenofibrate from the FDA, and is updated regularly.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,456 Fenofibrate users. Check the latest studies of Fenofibrate.

What is Abortion spontaneous?

Abortion spontaneous (naturally occurring miscarriage) is found to be associated with 1,008 drugs and 1,279 conditions by eHealthMe. Check the latest studies of Abortion spontaneous.

On Jul, 17, 2026

39,402 people reported to have side effects when taking Fenofibrate.
Among them, 28 people (0.07%) have Abortion spontaneous.

Could Fenofibrate cause Abortion spontaneous?

Among these 28 people:

How long have people been on Fenofibrate when they have Abortion spontaneous? *

What is the age of people who have Abortion spontaneous when taking Fenofibrate? *

What are other drugs people take besides Fenofibrate? *

What are other side effects people have besides Abortion spontaneous? *

Vaginal Bleeding: 7 people, 25.00%
Maternal Exposure During Pregnancy (use of substance during pregnancy): 6 people, 21.43%
Abdominal Pain: 5 people, 17.86%
Headache (pain in head): 5 people, 17.86%
Hypoaesthesia (reduced sense of touch or sensation): 4 people, 14.29%
High Blood Pressure: 4 people, 14.29%
Drug Exposure During Pregnancy: 4 people, 14.29%
Gingivitis (inflammation of gums): 3 people, 10.71%
Migraine (headache): 3 people, 10.71%
Memory Loss: 3 people, 10.71%

What are the existing conditions these people have? *

Hyperlipidaemia (presence of excess lipids in the blood): 10 people, 35.71%
Polycystic Ovary Disease (cysts in the ovaries that occurs when the follicle stops developing): 9 people, 32.14%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 3 people, 10.71%
Weight Loss: 2 people, 7.14%
Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 7.14%
Gingival Disorder (gum disease): 2 people, 7.14%
Intervertebral Disc Protrusion (spinal disc protrusion): 2 people, 7.14%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 7.14%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 7.14%
Migraine (headache): 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Fenofibrate and have Abortion spontaneous?

- Check whether Abortion spontaneous is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fenofibrate:

Fenofibrate (40,456 reports)

Browse all side effects of Fenofibrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abortion spontaneous:

Abortion spontaneous (1,008 drugs)

Browse all the conditions that are associated with Abortion spontaneous:

Abortion spontaneous (1,279 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fenofibrate (the active ingredients of Fenofibrate) and Fenofibrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.